NOTICE: FDA Grants Emergency Use Authorizationexternal icon for Johnson & Johnson's/Janssen COVID-19 Vaccine
The Advisory Committee on Immunization Practices (ACIP) is meeting to discuss a recommendation for the use of J&J/Janssen’s COVID-19 vaccine for the prevention of COVID-19 in persons aged 18 years and older.
Talking to Recipients about COVID-19 Vaccines
Many people have questions about the new coronavirus disease 2019 (COVID-19) vaccines. As vaccine recipients’ most-trusted source of information on vaccines, you play a critical role in helping them understand the importance of COVID-19 vaccination, as well as if and when it is likely to be recommended for them.
The materials below include proven communication strategies and tips for effectively setting expectations and addressing questions from COVID-19 vaccine recipients.